|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
VanEck Is Getting Closer to Launching a Spot BNB ETF
Apr 03, 2025 at 12:29 am
An American exchange-traded fund (ETF) based on Binance Coin (BNB) is getting closer to launch at the worldwide investment management firm VanEck.

An American exchange-traded fund (ETF) based on Binance Coin (BNB) is getting closer to launch at the worldwide investment management firm VanEck.
What Happened: Signifying a significant move toward bringing BNB into conventional financial markets, the firm filed a business in Delaware on March 31.
The company is now listed on the Delaware Division of Corporations' website as ‘VanEck BNB ETF, Trust, Corporate Service Corporation.’ It is registered under file number 10148820.
This new development follows a series of applications by VanEck for crypto ETFs earlier in 2024. These include Bitcoin (BTC), Ether (ETH), Solana (SOL), and Avalanche (AVAX) ETFs, showcasing the firm’s broader strategy in tapping into the burgeoning digital asset investment sector.
Why It's Important: This application is the first documented effort to create a spot BNB ETF in the United States.
Such a vehicle would allow for the controlled investment in Binance Coin to be made accessible to a broader spectrum of investors, including both institutional and retail participants.
It also aligns with the broader trend of crypto ETF applications in the U.S. in 2024.
Earlier this year, 21Shares and partners applied to list several crypto ETFs on the Euronext exchange in Paris. Among these is a BNB ETF, aiming to expand European investors' options for investing in Binance Coin.
The 21Shares BNB ETP (CRYPTO: 21BCOIN) was first introduced in Switzerland back in October 2019. Its goal is to provide capital markets investors with a specific and focused investment in Binance Coin.
The 21Shares ETP is a fully-hedged ETP, ensuring complete exposure to the price of Binance Coin. It is actively managed and charges an annual management fee of 1%.
According to TradingView data, the 21Shares BNB ETP currently manages about $15 million in assets. This constitutes 0.3% of Switzerland’s total crypto AUM, which stands at $5.3 billion as of March 28.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































